These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15314882)

  • 21. [Unconventional cancer therapy on trial. Mistletoe preparations: only effective in the test tube?. Interview by Elke Runge].
    Beuth J
    MMW Fortschr Med; 2000 Mar; 142(9):14. PubMed ID: 10795476
    [No Abstract]   [Full Text] [Related]  

  • 22. Complementary and alternative pain therapy in the emergency department.
    Dillard JN; Knapp S
    Emerg Med Clin North Am; 2005 May; 23(2):529-49. PubMed ID: 15829396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of complementary and alternative medicine by cancer patients at the University of Nigeria Teaching Hospital, Enugu, Nigeria.
    Ezeome ER; Anarado AN
    BMC Complement Altern Med; 2007 Sep; 7():28. PubMed ID: 17850665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality assurance and safety of herbal dietary supplements.
    Fu PP; Chiang HM; Xia Q; Chen T; Chen BH; Yin JJ; Wen KC; Lin G; Yu H
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2009 Apr; 27(2):91-119. PubMed ID: 19412857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nationwide survey on complementary and alternative medicine in cancer patients in Japan.
    Hyodo I; Amano N; Eguchi K; Narabayashi M; Imanishi J; Hirai M; Nakano T; Takashima S
    J Clin Oncol; 2005 Apr; 23(12):2645-54. PubMed ID: 15728227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Herbal and complementary medicine in dermatology.
    Dattner AM
    Dermatol Clin; 2004 Jul; 22(3):325-32, vii. PubMed ID: 15207314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Remission of hormone-refractory prostate cancer attributed to Essiac.
    Al-Sukhni W; Grunbaum A; Fleshner N
    Can J Urol; 2005 Oct; 12(5):2841-2. PubMed ID: 16274521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Herbs and dietary supplement use in patients with stage 5 chronic kidney disease.
    Burrowes JD; Van Houten G
    Nephrol Nurs J; 2006; 33(1):85-8. PubMed ID: 16538934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteoporosis risk and interest in strength training in men receiving androgen ablation therapy for locally advanced prostate cancer.
    Ott C; Fulton MK
    J Am Acad Nurse Pract; 2005 Mar; 17(3):113-22. PubMed ID: 15748224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Future direction of complementary and alternative medicine (CAM) education and research.
    Wyatt G; Post-White J
    Semin Oncol Nurs; 2005 Aug; 21(3):215-24. PubMed ID: 16092810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review of dietary supplement-induced renal dysfunction.
    Gabardi S; Munz K; Ulbricht C
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):757-65. PubMed ID: 17699493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complementary and alternative (CAM) dietary therapies for cancer.
    Weitzman S
    Pediatr Blood Cancer; 2008 Feb; 50(2 Suppl):494-7; discussion 498. PubMed ID: 18064662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complementary therapies for cancer-related symptoms.
    Deng G; Cassileth BR; Yeung KS
    J Support Oncol; 2004; 2(5):419-26; discussion 427-9. PubMed ID: 15524070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complementary/alternative medicine use in a pediatric oncology unit in Turkey.
    Karadeniz C; Pinarli FG; Oğuz A; Gürsel T; Canter B
    Pediatr Blood Cancer; 2007 May; 48(5):540-3. PubMed ID: 16900485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What is an exceptional cancer trajectory?: Multiple stakeholder perspectives on cancer trajectories in relation to complementary and alternative medicine use.
    Hök J; Forss A; Falkenberg T; Tishelman C
    Integr Cancer Ther; 2009 Jun; 8(2):153-63. PubMed ID: 19679624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CAM Research attempts to separate wheat from chaff.
    Voelker R
    JAMA; 2001 Jul; 286(2):156-8. PubMed ID: 11448264
    [No Abstract]   [Full Text] [Related]  

  • 37. Pushed and pulled: the role of affect and cognition in shaping CAM attitudes and behavior among men treated for prostate cancer.
    Porter MC; Diefenbach MA
    J Health Psychol; 2009 Mar; 14(2):288-96. PubMed ID: 19237496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Harnessing the anticancer power of plants.
    Talalay P
    Johns Hopkins Med Lett Health After 50; 2002 Dec; 14(10):6. PubMed ID: 12523262
    [No Abstract]   [Full Text] [Related]  

  • 39. Complementary and alternative medicine use in patients with haematological malignancies in Europe.
    Molassiotis A; Margulies A; Fernandez-Ortega P; Pud D; Panteli V; Bruyns I; Scott JA; Gudmundsdottir G; Browall M; Madsen E; Ozden G; Magri M; Selvekerova S; Platin N; Kearney N; Patiraki E
    Complement Ther Clin Pract; 2005 May; 11(2):105-10. PubMed ID: 15955292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of complementary and alternative medicine among patients with chronic diseases at outpatient clinics.
    Hasan SS; Ahmed SI; Bukhari NI; Loon WC
    Complement Ther Clin Pract; 2009 Aug; 15(3):152-7. PubMed ID: 19595416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.